These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27825128)

  • 1. Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy.
    Paret C; Theruvath J; Russo A; Kron B; El Malki K; Lehmann N; Wingerter A; Neu MA; Gerhold-Ay A; Wagner W; Sommer C; Pietsch T; Seidmann L; Faber J
    Oncotarget; 2016 Dec; 7(50):83378-83391. PubMed ID: 27825128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor Patients.
    Vewinger N; Huprich S; Seidmann L; Russo A; Alt F; Bender H; Sommer C; Samuel D; Lehmann N; Backes N; Roth L; Harter PN; Filipski K; Faber J; Paret C
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular identification of CNS NB-FOXR2, CNS EFT-CIC, CNS HGNET-MN1 and CNS HGNET-BCOR pediatric brain tumors using tumor-specific signature genes.
    Łastowska M; Trubicka J; Sobocińska A; Wojtas B; Niemira M; Szałkowska A; Krętowski A; Karkucińska-Więckowska A; Kaleta M; Ejmont M; Perek-Polnik M; Dembowska-Bagińska B; Grajkowska W; Matyja E
    Acta Neuropathol Commun; 2020 Jul; 8(1):105. PubMed ID: 32650833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis.
    Ferris SP; Velazquez Vega J; Aboian M; Lee JC; Van Ziffle J; Onodera C; Grenert JP; Saunders T; Chen YY; Banerjee A; Kline CN; Gupta N; Raffel C; Samuel D; Ruiz-Diaz I; Magaki S; Wilson D; Neltner J; Al-Hajri Z; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Schniederjan M; Cha S; Perry A; Solomon DA
    Brain Pathol; 2020 Jan; 30(1):46-62. PubMed ID: 31104347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNS high-grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue.
    Yoshida Y; Nobusawa S; Nakata S; Nakada M; Arakawa Y; Mineharu Y; Sugita Y; Yoshioka T; Araki A; Sato Y; Takeshima H; Okada M; Nishi A; Yamazaki T; Kohashi K; Oda Y; Hirato J; Yokoo H
    Brain Pathol; 2018 Sep; 28(5):710-720. PubMed ID: 29226988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HGNET-BCOR Tumors of the Cerebellum: Clinicopathologic and Molecular Characterization of 3 Cases.
    Appay R; Macagno N; Padovani L; Korshunov A; Kool M; André N; Scavarda D; Pietsch T; Figarella-Branger D
    Am J Surg Pathol; 2017 Sep; 41(9):1254-1260. PubMed ID: 28704208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy.
    Paret C; Russo A; Otto H; Mayer A; Zahnreich S; Wagner W; Samuel D; Scharnhorst D; Solomon DA; Dhall G; Wong K; Bender H; Alt F; Wingerter A; Neu MA; Beck O; Prawitt D; Eder S; Henninger N; El Malki K; Lehmann N; Backes N; Roth L; Seidmann L; Sommer C; Brockmann MA; Staatz G; Schmidberger H; Faber J
    Oncotarget; 2017 Dec; 8(69):114210-114225. PubMed ID: 29371980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mouse model for embryonal tumors with multilayered rosettes uncovers the therapeutic potential of Sonic-hedgehog inhibitors.
    Neumann JE; Wefers AK; Lambo S; Bianchi E; Bockstaller M; Dorostkar MM; Meister V; Schindler P; Korshunov A; von Hoff K; Nowak J; Warmuth-Metz M; Schneider MR; Renner-Müller I; Merk DJ; Shakarami M; Sharma T; Chavez L; Glass R; Chan JA; Taketo MM; Neumann P; Kool M; Schüller U
    Nat Med; 2017 Oct; 23(10):1191-1202. PubMed ID: 28892064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of apoptotic genes and downregulation of target genes of Sonic Hedgehog signaling pathway in DAOY medulloblastoma cell line treated with arsenic trioxide.
    Ghorbanlou M; Moradi F; Shabani R; Mehdizadeh M
    J Chemother; 2024 Oct; 36(6):506-519. PubMed ID: 38130211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central nervous system high grade neuroepithelial tumor with BCOR immunopositivity: Is there a molecular heterogeneity?
    Rao S; Mitra S; Sugur H; Vazhayil V; Rao BRM; Annayappa SK; Nandeesh BN; Yasha TC; Santosh V
    Brain Tumor Pathol; 2021 Jan; 38(1):41-49. PubMed ID: 32980923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system high-grade neuroepithelial tumor with BCOR alteration (CNS HGNET-BCOR)-case-based reviews.
    De Lima L; Sürme MB; Gessi M; Mastronuzzi A; Miele E; Tamburrini G; Massimi L
    Childs Nerv Syst; 2020 Aug; 36(8):1589-1599. PubMed ID: 32542405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sonic hedgehog signaling pathway in Myelodysplastic Syndrome: Abnormal activation and jervine intervention.
    Qin Y; Jiang M; Tuerxung N; Wang H; Zhao F; Zhen Y; Hao J
    Gene; 2020 Sep; 754():144881. PubMed ID: 32526259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hedgehog Pathway Alterations Downstream of Patched-1 Are Common in Infundibulocystic Basal Cell Carcinoma.
    Russell-Goldman E; MacConaill L; Hanna J
    Am J Dermatopathol; 2021 Apr; 43(4):266-272. PubMed ID: 32796174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hedgehog Signaling and Truncated GLI1 in Cancer.
    Doheny D; Manore SG; Wong GL; Lo HW
    Cells; 2020 Sep; 9(9):. PubMed ID: 32957513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Wound Site Seeding in a Patient with Central Nervous System High-Grade Neuroepithelial Tumor with BCOR Alteration.
    Kirkman MA; Pickles JC; Fairchild AR; Avery A; Pietsch T; Jacques TS; Aquilina K
    World Neurosurg; 2018 Aug; 116():279-284. PubMed ID: 29859355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single supratentorial high-grade neuroepithelial tumor with two distinct BCOR mutations, exceptionally long complete remission and survival.
    Bremer J; Kottke R; Johann PD; von Hoff K; Brazzola P; Grotzer MA; Kool M; Rushing E; Gerber NU
    Pediatr Blood Cancer; 2020 Jul; 67(7):e28384. PubMed ID: 32383815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance.
    Gruber W; Hutzinger M; Elmer DP; Parigger T; Sternberg C; Cegielkowski L; Zaja M; Leban J; Michel S; Hamm S; Vitt D; Aberger F
    Oncotarget; 2016 Feb; 7(6):7134-48. PubMed ID: 26784250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression.
    Tang CM; Lee TE; Syed SA; Burgoyne AM; Leonard SY; Gao F; Chan JC; Shi E; Chmielecki J; Morosini D; Wang K; Ross JS; Kendrick ML; Bardsley MR; Siena M; Mao J; Harismendy O; Ordog T; Sicklick JK
    Oncotarget; 2016 Nov; 7(48):78226-78241. PubMed ID: 27793025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of BCOR Internal Tandem Duplications in Pediatric Cancers by Targeted RNA Sequencing.
    Al-Ibraheemi A; Putra J; Tsai HK; Cano S; Lip V; Pinches RS; Restrepo T; Alexandrescu S; Janeway KA; Duraisamy S; Harris MH; Church AJ
    J Mol Diagn; 2021 Oct; 23(10):1269-1278. PubMed ID: 34325058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features.
    Torre M; Meredith DM; Dubuc A; Solomon DA; Perry A; Vasudevaraja V; Serrano J; Snuderl M; Ligon KL; Alexandrescu S
    J Neuropathol Exp Neurol; 2019 Apr; 78(4):305-314. PubMed ID: 30816933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.